Target intelligence / Profile preview

Clostridioides difficile toxin A (TcdA)

Target
TcdA
Molecular classification
Toxin, Enzyme (Glucosyltransferase)
01

Overview

Clostridioides difficile toxin A (TcdA) is a large exotoxin produced by the bacterium *Clostridioides difficile*. It is a major virulence factor contributing to the pathogenesis of C. difficile infection. TcdA functions as an enterotoxin and cytotoxin, disrupting intestinal epithelial barrier function by inactivating Rho GTPases through glucosylation. This leads to inflammation, cell damage, and the characteristic symptoms of CDI, including pseudomembranous colitis.

Other names
Clostridium difficile toxin AtoxA producttcdA product
02

Mechanism of action

Receptor binding -> Endocytosis -> Autoproteolysis -> Glucosylation/inactivation of Rho GTPases

03

Biological functions

CytotoxicityEnterotoxicityDisruption of epithelial barrier functionInflammation inductionRho GTPase inactivation
04

Disease associations

Clostridioides difficile infection (CDI)Pseudomembranous colitisEnterocolitis
05

Safety considerations

Toxemia leading to systemic effects (cardiac, renal, neurologic)Induction of inflammation

Beyond the preview

Go deeper on Clostridioides difficile toxin A (TcdA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clostridioides difficile toxin A (TcdA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call